Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Children's Hospital Denver
1154
mi
from 43215
Aurora, CO
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Children's Hospital Denver
1154
mi
from 43215
Aurora, CO
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Howard University Hospital
328
mi
from 43215
Washington,
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Howard University Hospital
328
mi
from 43215
Washington,
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
University of Miami School of Medicine
993
mi
from 43215
Miami, FL
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
University of Miami School of Medicine
993
mi
from 43215
Miami, FL
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Georgia Health Sciences University
457
mi
from 43215
Augusta, GA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Georgia Health Sciences University
457
mi
from 43215
Augusta, GA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
University of Illinois College of Medicine
276
mi
from 43215
Chicago, IL
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
University of Illinois College of Medicine
276
mi
from 43215
Chicago, IL
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
LSU Health Science Center Shreveport
789
mi
from 43215
Shreveport, LA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
LSU Health Science Center Shreveport
789
mi
from 43215
Shreveport, LA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Tufts Clinical Pharmacology Study Unit
643
mi
from 43215
Boston, MA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
643
mi
from 43215
Boston, MA
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Albert Einstein College of Medicine
486
mi
from 43215
Bronx, NY
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
486
mi
from 43215
Bronx, NY
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
University of North Carolina Hospital at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
UT Soutwestern Medical Center at Dallas
911
mi
from 43215
Dallas, TX
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
911
mi
from 43215
Dallas, TX
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Baylor University Medical Center - Dallas
909
mi
from 43215
Dallas, TX
A Study of HQK-1001 in Patients With Sickle Cell Disease
A Randomized, Open-Label, Multi-Dose Study of HQK-1001 in Subjects With Sickle Cell Disease
Status: Archived
Updated: 1/1/1970
Baylor University Medical Center - Dallas
909
mi
from 43215
Dallas, TX
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study
Status: Archived
Children's Doctor
996
mi
from 43215
Houston, TX
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study
Status: Archived
Updated: 1/1/1970
Children's Doctor
996
mi
from 43215
Houston, TX
Biomarkers Serum Collection Methodology Study
BIOMARKERS SERUM COLLECTION METHODOLOGY PILOT STUDY
Status: Archived
Georgetown University Medical Center/Lombardi Cancer Institute
329
mi
from 43215
Washington,
Biomarkers Serum Collection Methodology Study
BIOMARKERS SERUM COLLECTION METHODOLOGY PILOT STUDY
Status: Archived
Updated: 1/1/1970
Georgetown University Medical Center/Lombardi Cancer Institute
329
mi
from 43215
Washington,
Evaluation of Safety and Efficacy of TXA127 to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation Transplant
Phase I Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation
Status: Archived
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Evaluation of Safety and Efficacy of TXA127 to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation Transplant
Phase I Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Adults Undergoing Double Cord Blood Transplantation
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia
Status: Archived
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia - A
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected by Hypohidrotic Ectodermal Dysplasia
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Emory University
435
mi
from 43215
Atlanta, GA
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Updated: 1/1/1970
Emory University
435
mi
from 43215
Atlanta, GA
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Blood and Marrow Transplant Group of Georgia
427
mi
from 43215
Atlanta, GA
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Updated: 1/1/1970
Blood and Marrow Transplant Group of Georgia
427
mi
from 43215
Atlanta, GA
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Indiana University
167
mi
from 43215
Indianapolis, IN
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Updated: 1/1/1970
Indiana University
167
mi
from 43215
Indianapolis, IN
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Multiple Myeloma Patients
Status: Archived
Updated: 1/1/1970
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
1645
mi
from 43215
Scottsdale, AZ
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Collecting and Storing Blood Samples From Patients With Cancer
Banking DNA for Analysis of Genetic Polymorphisms in Patients With Cancer
Status: Archived
University of Medicine and Dentistry - Robert Wood Johnson University Hospital
453
mi
from 43215
New Brunswick, NJ
Collecting and Storing Blood Samples From Patients With Cancer
Banking DNA for Analysis of Genetic Polymorphisms in Patients With Cancer
Status: Archived
Updated: 1/1/1970
University of Medicine and Dentistry - Robert Wood Johnson University Hospital
453
mi
from 43215
New Brunswick, NJ
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Providence Cancer Center at Providence Hospital
703
mi
from 43215
Mobile, AL
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Providence Cancer Center at Providence Hospital
703
mi
from 43215
Mobile, AL
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Highlands Oncology Group - Springdale
657
mi
from 43215
Bentonville, AR
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Highlands Oncology Group - Springdale
657
mi
from 43215
Bentonville, AR
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
USC Norris Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
USC Norris Comprehensive Cancer Center
1982
mi
from 43215
Los Angeles, CA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Veterans Affairs Medical Center - Hines
283
mi
from 43215
Hines, IL
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Hines
283
mi
from 43215
Hines, IL
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Menorah Medical Center
623
mi
from 43215
Overland Park, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Menorah Medical Center
623
mi
from 43215
Overland Park, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
St Luke'S Hospital And Health Network
405
mi
from 43215
Bethlehem, PA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
St Luke'S Hospital And Health Network
405
mi
from 43215
Bethlehem, PA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Mowery Clinic LLC Tammy Walker Cancer Center
782
mi
from 43215
Salina, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Mowery Clinic LLC Tammy Walker Cancer Center
782
mi
from 43215
Salina, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Shawnee Mission Hospital
624
mi
from 43215
Shawnee Mission, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Shawnee Mission Hospital
624
mi
from 43215
Shawnee Mission, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Cotton-O'Neil Cancer Center
678
mi
from 43215
Topeka, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Cotton-O'Neil Cancer Center
678
mi
from 43215
Topeka, KA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Tulane Cancer Center Office of Clinical Research
804
mi
from 43215
Alexandria, LA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Tulane Cancer Center Office of Clinical Research
804
mi
from 43215
Alexandria, LA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Lahey Clinic Medical Center - Burlington
638
mi
from 43215
Burlington, MA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Lahey Clinic Medical Center - Burlington
638
mi
from 43215
Burlington, MA
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Josephine Ford Cancer Center at Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Josephine Ford Cancer Center at Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Clemens Regional Medical Center
181
mi
from 43215
Mount Clemens, MI
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Clemens Regional Medical Center
181
mi
from 43215
Mount Clemens, MI
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
University of Mississippi
660
mi
from 43215
Jackson, MS
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
University of Mississippi
660
mi
from 43215
Jackson, MS
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Heartland Hematology-Oncology
616
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Heartland Hematology-Oncology
616
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
CCOP - Kansas City
619
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
CCOP - Kansas City
619
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Parvin Radiation Oncology
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Parvin Radiation Oncology
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
St. Joseph Medical Center
620
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
St. Joseph Medical Center
620
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
North Kansas City Hospital
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
North Kansas City Hospital
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Research Medical Center
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Research Medical Center
617
mi
from 43215
Kansas City, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Saint Luke's East - Lee's Summit
606
mi
from 43215
Lee's Summit, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Saint Luke's East - Lee's Summit
606
mi
from 43215
Lee's Summit, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Liberty Hospital
608
mi
from 43215
Liberty, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Liberty Hospital
608
mi
from 43215
Liberty, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
St. Joseph Oncology, INC
624
mi
from 43215
St. Joseph, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
St. Joseph Oncology, INC
624
mi
from 43215
St. Joseph, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Heartland Regional Medical Center
624
mi
from 43215
Saint Joseph, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
Heartland Regional Medical Center
624
mi
from 43215
Saint Joseph, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
St Louis Children's Hospital
397
mi
from 43215
St Louis, MO
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
Status: Archived
Updated: 1/1/1970
St Louis Children's Hospital
397
mi
from 43215
St Louis, MO